| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |